Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Keshava Rajagopal

Thoracic Surgery (Cardiothoracic Vascular Surgery) Houston, TX Medical Doctor

NPI 1295993889 CMS profile 331412

800 Peakwood Dr Ste 5D, Ste 2350, Houston, TX 77090

Open in the dashboard

General payments

$7,907

109 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Keshava Rajagopal of Houston, TX is reported in the CMS Open Payments database as having received $7,907 across 109 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,199 25
2024 General $1,530 26
2023 General $286 8
2022 General $771 9
2021 General $540 10
2020 General $432 14
2019 General $1,149 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keshava Rajagopal
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Keshava Rajagopal were reported at $3,199. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Keshava Rajagopal Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,149 $886 $178–$3,167 $163
2020 $432 $341 $108–$1,605 $114
2021 $540 $453 $125–$1,886 $132
2022 $771 $695 $180–$2,566 $149
2023 $286 $745 $205–$2,662 $160
2024 $1,530 $799 $214–$2,967 $164
2025 $3,199 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $2,465 35 payments
  2. Abiomed $1,489 20 payments
  3. Paladin Technology Solutions $1,312 8 payments
  4. Medtronic, Inc. $597 5 payments
  5. Baxter Healthcare $365 2 payments
  6. Medtronic Vascular, Inc. $313 13 payments
  7. Arthrex, Inc. $292 3 payments
  8. Atricure, Inc. $229 7 payments
  9. Edwards Lifesciences Corporation $181 2 payments
  10. Boston Scientific Corporation $148 5 payments
  11. Other $515 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,150 101 payments
  2. Travel and Lodging $2,757 8 payments
Products named General payments · program years 2019–2025
  1. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Structural Heart $1,518 15 payments
  2. Impella $1,344 18 payments
  3. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $537 11 payments
  4. HeartWare HVAD $313 13 payments
  5. FLOSEAL $245 1 payment
  6. HeartMate 3 Left Ventricular Assist Device $179 3 payments
  7. Mosaic $155 1 payment
  8. LifeVest $147 3 payments
  9. CentriMag $125 1 payment
  10. ETHICON $125 1 payment
  11. Other $1,103 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$76,634

Medicare's payments for the services billed

Medicare patients

85

Average age 69

Services billed

252

29 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 73%
Atrial fibrillation 62%
Chronic kidney disease 60%
Diabetes 48%
COPD 35%
Arthritis 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

109 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record